Venaxis Inc (NASDAQ:APPY)

Data as of Sep 16
 -0.02 / -1.19%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Venaxis, Inc. is a vitro diagnostic company, which is focused on advancing products that addresses unmet human diagnostic needs. The company's research and development activities are currently focused primarily on a human acute appendicitis blood-based test. It is in the business of development and commercialization of innovative products. Venaxis was founded on July 24, 2000 and is headquartered in Castle Rock, CO.

Contact Information

Venaxis, Inc.
1585 South Perry Street
Castle Rock Colorado 80104
P:(303) 794-2000
Investor Relations:



Other institutional16.07%
Mutual fund holders11.52%
Individual stakeholders0.28%

Top Executives

Stephen T. LundyPresident, Chief Executive Officer & Director
Jeffrey G. McGonegalChief Financial Officer & Secretary
Lyndal K. HesterbergHead-Research & Development
Donald R. HurdChief Commercial Officer & Senior Vice President
Glen Paul FreibergHead-Regulatory Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.